Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 0.93 is 87% below its 5-year average of 7.00, near the low end of its 5-year range (0.87–17.12).
As of the fiscal period ended Tuesday, June 30, 2026. 12.26% below its 12-month average of 1.06.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.93.
CURRENT RATIO
0.93
CURRENT RATIO AVG TTM
1.06
CURRENT RATIO AVG 3Y
3.50
CURRENT RATIO AVG 5Y
7.00
CURRENT RATIO AVG 10Y
11.60
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-12.26%
CURRENT VS 3Y AVG
-73.35%
CURRENT VS 5Y AVG
-86.69%
CURRENT VS 10Y AVG
-91.97%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.60
median of 797 covered companies
CURRENT VS SECTOR MEDIAN
-74.12%
vs the sector median at left
Market Cap
$259.46M
Current Ratio
11.30
TTM Avg
6.79
3Y Avg
6.17
5Y Avg
6.32
Market Cap
$258.09M
Current Ratio
4.48
TTM Avg
4.80
3Y Avg
5.23
5Y Avg
5.23
Market Cap
$262.65M
Current Ratio
13.89
TTM Avg
8.37
3Y Avg
7.38
5Y Avg
15.00
Market Cap
$264.84M
Current Ratio
15.82
TTM Avg
24.04
3Y Avg
14.70
5Y Avg
12.06
Market Cap
$265.41M
Current Ratio
8.88
TTM Avg
8.27
3Y Avg
7.75
5Y Avg
6.94
Market Cap
$265.50M
Current Ratio
16.00
TTM Avg
13.11
3Y Avg
8.33
5Y Avg
7.81
Market Cap
$266.20M
Current Ratio
4.50
TTM Avg
8.35
3Y Avg
6.79
5Y Avg
6.91
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AC Immune S.A. (ACIU) | $259.52M | 0.93 | 1.06 | 3.50 | 7.00 |
| X4 Pharmaceuticals, Inc. (XFOR)vs › | $259.46M | 11.30 | 6.79 | 6.17 | 6.32 |
| Palisade Bio, Inc. (PALI)vs › | $261.24M | 24.26 | 16.09 | 10.56 | 7.83 |
| Anika Therapeutics, Inc. (ANIK)vs › | $258.09M | 4.48 | 4.80 | 5.23 | 5.23 |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $262.65M | 13.89 | 8.37 | 7.38 | 15.00 |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $264.84M | 15.82 | 24.04 | 14.70 | 12.06 |
| OraSure Technologies, Inc. (OSUR)vs › | $265.41M | 8.88 | 8.27 | 7.75 | 6.94 |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $265.50M | 16.00 | 13.11 | 8.33 | 7.81 |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $266.20M | 4.50 | 8.35 | 6.79 | 6.91 |
| Sol-Gel Technologies Ltd. (SLGL)vs › | $251.29M | 10.37 | 5.14 | 8.08 | 7.69 |
Current Ratio
0.93
Quick Ratio
0.93
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 0.93 |
| 2026-03-31 | 0.87 |
| 2025-12-31 | 1.02 |
| 2025-09-30 | 1.16 |
| 2025-06-30 | 1.33 |
| 2025-03-31 | 1.53 |
| 2024-12-31 | 1.71 |
| 2024-09-30 | 1.86 |
| 2024-06-30 | 1.80 |
| 2024-03-31 | 7.78 |
| 2023-12-31 | 9.22 |
| 2023-09-30 | 7.36 |
| 2023-06-30 | 8.89 |
| 2023-03-31 | 10.38 |
| 2022-12-31 | 11.16 |
| 2022-09-30 | 10.85 |
| 2022-06-30 | 13.28 |
| 2022-03-31 | 14.87 |
| 2021-12-31 | 10.12 |
| 2021-09-30 | 13.74 |
| 2021-06-30 | 17.12 |
| 2021-03-31 | 19.82 |
| 2020-12-31 | 16.53 |
| 2020-09-30 | 18.10 |
| 2020-06-30 | 20.63 |
| 2020-03-31 | 21.28 |
| 2019-12-31 | 16.72 |
| 2019-09-30 | 22.08 |
| 2019-06-30 | 21.90 |
| 2019-03-31 | 5.06 |
| 2018-12-31 | 14.75 |
| 2018-09-30 | 19.21 |
| 2018-06-30 | 9.65 |
| 2018-03-31 | 13.58 |
| 2017-12-31 | 13.28 |
| 2017-09-30 | 14.93 |
| 2017-06-30 | 21.60 |
| 2017-03-31 | 18.60 |
| 2016-12-31 | 15.61 |
| 2016-09-30 | 14.50 |
| 2016-06-30 | 10.74 |
| 2016-03-31 | 12.39 |
| 2015-12-31 | 13.01 |
| 2015-09-30 | 14.79 |
| 2015-06-30 | 11.54 |
| 2015-03-31 | 0.00 |
| 2014-12-31 | 6.71 |
| 2014-09-30 | 0.00 |
| 2014-06-30 | 0.00 |
| 2014-03-31 | 0.00 |
